FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Campochiaro

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Disorders

Physiology

Blood-Retinal Barrier

Co-author Network

Publications

TOP 3
Robert B Bhisitkul; Peter A Campochiaro; Howard Shapiro; Roman G Rubio
Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography.
Lars G Fritsche; Asbjorg Geirsdottir; Ronnie J George; Christian Gieger; Michael B Gorin; Neel Gupta; Robyn H Guymer; Gregory S Hageman; Stephanie A Hagstrom; Jonathan L Haines; Gregory Hannum; Simon P Harding; Christos Haritoglou; John R Heckenlively; Iris M Heid; Frank G Holz; Guy Hughes; Robert P Igo; John P A Ioannidis; Tatsuro Ishibashi; Sudha K Iyengar; Peronne Joseph; Gyungah Jun; Yoichiro Kamatani; Nicholas Katsanis; Jane C Khan; Ivana K Kim; Yutaka Kiyohara; Caroline C W Klaver; Barbara E K Klein; Michael L Klein; Ronald Klein; Jaclyn L Kovach; Igor Kozak; Michiaki Kubo; G Mark Lathrop; Clara J Lee; Kristine E Lee; Thierry Léveillard; Peter Lichtner; Andrew J Lotery; Thomas Meitinger; Joanna E Merriam; Paul Mitchell; Saddek Mohand-Saïd; Anthony T Moore; Denise J Morgan; Margaux A Morrison; Chelsea E Myers; Claudia N Keilhauer; Adam C Naj; Yusuke Nakamura; Yukinori Okada; Anton Orlin; M Carolina Ortube; Mohammad I Othman; Chris Pappas; Kyu Hyung Park; Gayle J T Pauer; Neal S Peachey; Margaret A Pericak-Vance; Olivier Poch; Rinki Ratna Priya; Robyn Reynolds; Andrea J Richardson; Stephan Ripke; Raymond Ripp; Guenther Rudolph; Euijung Ryu; José-Alain Sahel; Debra A Schaumberg; Hendrik P N Scholl; Matthew Schu; Stephen G Schwartz; William K Scott; Johanna M Seddon; Humma Shahid; Haraldur Sigurdsson; Giuliana Silvestri; Xueling Sim; Theru A Sivakumaran; R Theodore Smith; Lucia Sobrin; Eric H Souied; Dwight E Stambolian; Hreinn Stefansson; Kari Stefansson; Gwen M Sturgill-Short; Anand Swaroop; Atsushi Takahashi; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Nirubol Tosakulwong; Barbara J Truitt; Evangelia E Tsironi; André G Uitterlinden; Cornelia M van Duijn; Lingam Vijaya; Johannes R Vingerling; Eranga N Vithana; Jie Jin Wang; Bernhard H F Weber; Andrew R Webster; Daniel E Weeks; H-Erich Wichmann; Thomas W Winkler; Tien Y Wong; Alan F Wright; Brian L Yaspan; John R W Yates; Yi Yu; Donald J Zack; Diana Zelenika; Kang Zhang; Ming Zhang; Ling Zhao; Gonçalo R Abecasis; Anita Agarwal; Rando Allikmets; Satoshi Arakawa; Ana Maria Armbrecht; Isabelle Audo; Tin Aung; Paul N Baird; Gaetano R Barile; Mustapha Benchaboune; Alan C Bird; Paul N Bishop; Kari E Branham; Matthew Brooks; Alexander J Brucker; Gabriëlle H S Buitendijk; William H Cade; Melinda S Cain; Peter A Campochiaro; Chi-Chao Chan; Wei Chen; Ching-Yu Cheng; Emily Y Chew; Kimberly A Chin; Itay Chowers; Valentina Cipriani; David G Clayton; Radu Cojocaru; Yvette P Conley; Belinda K Cornes; Mark J Daly; Margaret M Deangelis; Baljean Dhillon; Albert O Edwards; Evangelos Evangelou; Jesen Fagerness; Lindsay A Farrer; Henry A Ferreyra; Peter J Francis; James S Friedman
Seven new loci associated with age-related macular degeneration.
Peter A Campochiaro; Robert B Bhisitkul; Howard Shapiro; Roman G Rubio
Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Campochiaro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Robert B Bhisitkul; Peter A Campochiaro; Howard Shapiro; Roman G Rubio
Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography.
Ophthalmology 2013;120(5):1057-63.
2013: Lars G Fritsche; Asbjorg Geirsdottir; Ronnie J George; Christian Gieger; Michael B Gorin; Neel Gupta; Robyn H Guymer; Gregory S Hageman; Stephanie A Hagstrom; Jonathan L Haines; Gregory Hannum; Simon P Harding; Christos Haritoglou; John R Heckenlively; Iris M Heid; Frank G Holz; Guy Hughes; Robert P Igo; John P A Ioannidis; Tatsuro Ishibashi; Sudha K Iyengar; Peronne Joseph; Gyungah Jun; Yoichiro Kamatani; Nicholas Katsanis; Jane C Khan; Ivana K Kim; Yutaka Kiyohara; Caroline C W Klaver; Barbara E K Klein; Michael L Klein; Ronald Klein; Jaclyn L Kovach; Igor Kozak; Michiaki Kubo; G Mark Lathrop; Clara J Lee; Kristine E Lee; Thierry Léveillard; Peter Lichtner; Andrew J Lotery; Thomas Meitinger; Joanna E Merriam; Paul Mitchell; Saddek Mohand-Saïd; Anthony T Moore; Denise J Morgan; Margaux A Morrison; Chelsea E Myers; Claudia N Keilhauer; Adam C Naj; Yusuke Nakamura; Yukinori Okada; Anton Orlin; M Carolina Ortube; Mohammad I Othman; Chris Pappas; Kyu Hyung Park; Gayle J T Pauer; Neal S Peachey; Margaret A Pericak-Vance; Olivier Poch; Rinki Ratna Priya; Robyn Reynolds; Andrea J Richardson; Stephan Ripke; Raymond Ripp; Guenther Rudolph; Euijung Ryu; José-Alain Sahel; Debra A Schaumberg; Hendrik P N Scholl; Matthew Schu; Stephen G Schwartz; William K Scott; Johanna M Seddon; Humma Shahid; Haraldur Sigurdsson; Giuliana Silvestri; Xueling Sim; Theru A Sivakumaran; R Theodore Smith; Lucia Sobrin; Eric H Souied; Dwight E Stambolian; Hreinn Stefansson; Kari Stefansson; Gwen M Sturgill-Short; Anand Swaroop; Atsushi Takahashi; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Nirubol Tosakulwong; Barbara J Truitt; Evangelia E Tsironi; André G Uitterlinden; Cornelia M van Duijn; Lingam Vijaya; Johannes R Vingerling; Eranga N Vithana; Jie Jin Wang; Bernhard H F Weber; Andrew R Webster; Daniel E Weeks; H-Erich Wichmann; Thomas W Winkler; Tien Y Wong; Alan F Wright; Brian L Yaspan; John R W Yates; Yi Yu; Donald J Zack; Diana Zelenika; Kang Zhang; Ming Zhang; Ling Zhao; Gonçalo R Abecasis; Anita Agarwal; Rando Allikmets; Satoshi Arakawa; Ana Maria Armbrecht; Isabelle Audo; Tin Aung; Paul N Baird; Gaetano R Barile; Mustapha Benchaboune; Alan C Bird; Paul N Bishop; Kari E Branham; Matthew Brooks; Alexander J Brucker; Gabriëlle H S Buitendijk; William H Cade; Melinda S Cain; Peter A Campochiaro; Chi-Chao Chan; Wei Chen; Ching-Yu Cheng; Emily Y Chew; Kimberly A Chin; Itay Chowers; Valentina Cipriani; David G Clayton; Radu Cojocaru; Yvette P Conley; Belinda K Cornes; Mark J Daly; Margaret M Deangelis; Baljean Dhillon; Albert O Edwards; Evangelos Evangelou; Jesen Fagerness; Lindsay A Farrer; Henry A Ferreyra; Peter J Francis; James S Friedman
Seven new loci associated with age-related macular degeneration.
Nature genetics 2013;45(4):433-9, 439e1-2.
2013: Peter A Campochiaro; Robert B Bhisitkul; Howard Shapiro; Roman G Rubio
Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion.
Ophthalmology 2013;120(4):795-802.
2013: Peter A Campochiaro; Roomasa Channa; Ulrike Fiedler; Jeffrey S Heier; Julia Hepp; Brian B Berger; David M Brown; Michael T Stumpp
Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II study.
American journal of ophthalmology 2013;155(4):697-704, 704.e1-2.
2013: Peter A Campochiaro
Ocular neovascularization.
Journal of molecular medicine (Berlin, Germany) 2013;91(3):311-21.
2013: Diana V Do; Gulnar Hafiz; Afsheen A Khwaja; Quan Dong Nguyen; Yasir J Sepah; Raafay Sophie; Peter A Campochiaro; Roomasa Channa
Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment.
JAMA ophthalmology 2013;131(2):139-45.
2013: Lili Lu; Christopher P Seidel; Rebecca K Stevens; Xinyi Wang; Yuan Yuan Gong; Sean F Hackett; Takeshi Iwase; Peter A Campochiaro
Suppression of GLUT1; a new strategy to prevent diabetic complications.
Journal of cellular physiology 2013;228(2):251-7.
2013: Mohamed A Ibrahim; Jai Balkissoon; Peter A Campochiaro; Diana V Do; J Kevin Donahue; Gulnar Hafiz; James T Handa; RICHARD RIVERS; Yasir J Sepah; Syed Mahmood Shah; Elizabeth Van Anden; Quan Dong Nguyen
Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin A-4 phosphate.
BMC pharmacology & toxicology 2013;14():7.
2013: Takeshi Iwase; Achim H Krauss; Raquel Lima e Silva; Brian C Oveson; Jikui Shen; Peter Adamson; David C Gale; Noriyasu Hashida; Peter A Campochiaro
Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit.
Investigative ophthalmology & visual science 2013;54(1):503-11.
2012: Quan Dong Nguyen; Syed Mahmood Shah; Jason Slakter; Peter L Sonkin; Robert Vitti; Alyson J Berliner; David J Browning; Peter A Campochiaro; Jesse Cedarbaum; Karen Chu; Diana V Do; Julia A Haller; Seenu M Hariprasad; Henry L Hudson; Avner Ingerman; Peter K Kaiser; William Mieler
Evaluation of very high- and very low-dose intravitreal aflibercept in patients with neovascular age-related macular degeneration.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2012;28(6):581-8.
2012: Peter A Campochiaro; Sanford Chen; Bruce Garretson; Kenneth Green; Amod Gupta; Seenu M Hariprasad; Frances E Kane; Barry Kapik; Andrew Pearson; Elias Reichel; Jose Ruiz-Moreno; Gisele Soubrane; Clare Bailey; Kathleen Billman; David Boyer; David M Brown
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.
Ophthalmology 2012;119(10):2125-32.
2012: Masayuki Ohnaka; Rebecca Stevens; Yuan Yuan Gong; Sean F Hackett; Takeshi Iwase; Katsuaki Miki; Peter A Campochiaro
Long-term expression of glial cell line-derived neurotrophic factor slows, but does not stop retinal degeneration in a model of retinitis pigmentosa.
Journal of neurochemistry 2012;122(5):1047-53.
2012: Lucia Sobrin; Eric H Souied; Perciliz L Tan; André G Uitterlinden; Cornelia M van Duijn; Johannes R Vingerling; Yi Yu; Donald J Zack; R Theodore Smith; Rando Allikmets; Paul N Baird; Gaetano R Barile; Timothy W Behrens; Tushar R Bhangale; Milam A Brantley; Gabriëlle H S Buitendijk; Peter A Campochiaro; Usha Chakravarthy; Kimberly A Chin; Mark J Daly; Jesen Fagerness; Robert R Graham; Ruth E Hogg; John Ioannidis; Nicholas Katsanis; Caroline C W Klaver; Aaron Y Lee; Nicolas Leveziel; Joanna E Merriam; Soumya Raychaudhuri; Robyn Reynolds; Andrea J Richardson; Stephan Ripke; Johanna M Seddon
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes.
Ophthalmology 2012;119(9):1874-85.
2012: Jeffrey S Heier; Peter A Campochiaro; Zhengrong Li; Roman G Rubio; Namrata Saroj; Linda Yau; Phillip Lai
Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
Ophthalmology 2012;119(4):802-9.
2012: Jimmy de Melo; Karla Hirokawa; Katsuaki Miki; Edwin S Monuki; Amir Rattner; Philip M Smallwood; Cristina Zibetti; Peter A Campochiaro; Seth Blackshaw
Injury-independent induction of reactive gliosis in retina by loss of function of the LIM homeodomain transcription factor Lhx2.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(12):4657-62.
2012: Peter A Campochiaro
Gene transfer for ocular neovascularization and macular edema.
Gene therapy 2012;19(2):121-6.
2012: Peter A Campochiaro
Anti-vascular endothelial growth factor treatment for retinal vein occlusions.
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde 2012;227 Suppl 1():30-5.
2011: Soumya Raychaudhuri; Robyn Reynolds; Stephan Ripke; Albert K Tai; Perciliz L Tan; Soumya Vemuri; Yi Yu; Donald J Zack; Betsy Campochiaro; Peter A Campochiaro; Kimberly Chin; Mark J Daly; Sivakumar Gowrisankar; Oleg Iartchouk; Nicholas Katsanis; Kate Montgomery; Johanna M Seddon
A rare penetrant mutation in CFH confers high risk of age-related macular degeneration.
Nature genetics 2011;43(12):1232-6.
2011: Shinichi Usui; Zhihao Wu; Eun-Young Choi; Takeshi Iwase; Young-Joon Jo; Sun Young Lee; Lili Lu; Brian C Oveson; Richard J Samulski; Peter A Campochiaro
Overexpression of SOD in retina: need for increase in H2O2-detoxifying enzyme in same cellular compartment.
Free radical biology & medicine 2011;51(7):1347-54.
2011: Peter A Campochiaro; Sarah Gray; S Young Lee; Wendy Yee Murahashi; CC Awh; David M Brown; Namrata Saroj; Roman G Rubio
Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.
Ophthalmology 2011;118(10):2041-9.
2011: Yi Yu; Donald J Zack; Haraldur Sigurdsson; R Theodore Smith; Lucia Sobrin; Eric H Souied; Kari Stefansson; Perciliz L Tan; Gudmar Thorleifsson; Unnur Thorsteinsdottir; André G Uitterlinden; Cornelia M van Duijn; Johannes R Vingerling; Rando Allikmets; Paul N Baird; Gaetano R Barile; timothy wayne behrens; Tushar R Bhangale; Milam A Brantley; Gabriëlle H S Buitendijk; Betsy Campochiaro; Peter A Campochiaro; Usha Chakravarthy; Kimberly A Chin; Mark J Daly; Evangelos Evangelou; Jesen Fagerness; Robert R Graham; Omar Gustafsson; Robyn H Guymer; Ruth Hogg; John Ioannidis; Nicholas Katsanis; Caroline C W Klaver; Aaron Y Lee; Phil H Lee; Nicolas Leveziel; Joanna E Merriam; Ward Ortmann; Soumya Raychaudhuri; Robyn Reynolds; Andrea J Richardson; Stephan Ripke; Luba D Robman; Johanna M Seddon
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration.
Human molecular genetics 2011;20(18):3699-709.
2011: Aling Dong; Jikui Shen; Mingbing Zeng; Peter A Campochiaro
Vascular cell-adhesion molecule-1 plays a central role in the proangiogenic effects of oxidative stress.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(35):14614-9.
2011: David M Brown; Peter A Campochiaro; Sarah Gray; Allen C Ho; Anthony P Adamis; Robert B Bhisitkul; Roman G Rubio; Namrata Saroj; Wendy Yee Murahashi
Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.
Ophthalmology 2011;118(8):1594-602.
2011: Sun Young Lee; Shinichi Usui; Abu-Bakr Zafar; Brian C Oveson; Young-Joon Jo; Lili Lu; Solmaz Masoudi; Peter A Campochiaro
N-Acetylcysteine promotes long-term survival of cones in a model of retinitis pigmentosa.
Journal of cellular physiology 2011;226(7):1843-9.
2011: Peter A Campochiaro
Gene transfer for neovascular age-related macular degeneration.
Human gene therapy 2011;22(5):523-9.
2011: Peter A Campochiaro; David M Brown; Andrew Pearson; Thomas Ciulla; David Boyer; Frank G Holz; Michael J Tolentino; Amod Gupta; Lilianne Duarte; Steven Madreperla; John Gonder; Barry Kapik; Kathleen Billman; Frances E Kane
Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.
Ophthalmology 2011;118(4):626-635.e2.
2011: Roomasa Channa; Michael Smith; Peter A Campochiaro
Treatment of macular edema due to retinal vein occlusions.
Clinical ophthalmology (Auckland, N.Z.) 2011;5():705-13.
2011: Brian C Oveson; Takeshi Iwase; Sean F Hackett; Sun Young Lee; Shinichi Usui; Thomas W Sedlak; Solomon H Snyder; Peter A Campochiaro; Jennifer U Sung
Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degeneration.
Journal of neurochemistry 2011;116(1):144-53.
2010: Peter A Campochiaro; Gulnar Hafiz; Roomasa Channa; Syed Mahmood Shah; Quan Dong Nguyen; Howard S Ying; Diana V Do; Ingrid Zimmer-Galler; Sharon D Solomon; Jennifer U Sung; Beena Syed
Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes.
Ophthalmology 2010;117(12):2387-2394.e1-5.
2010: Henry F Edelhauser; Cheryl L Rowe-Rendleman; Michael R Robinson; Daniel G Dawson; Gerald J Chader; Hans E Grossniklaus; Kay D Rittenhouse; Clive G Wilson; David A Weber; Baruch D Kuppermann; Karl G Csaky; TW Olsen; Uday B Kompella; V Michael Holers; Gregory S Hageman; Brian C Gilger; Peter A Campochiaro; Scott M Whitcup; Wai Wong
Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications.
Investigative ophthalmology & visual science 2010;51(11):5403-20.
2010: Quan Dong Nguyen; Syed Mahmood Shah; Afsheen A Khwaja; Roomasa Channa; Elham Hatef; Diana V Do; David Boyer; Jeffery S Heier; Prema Abraham; Allen B Thach; Eugene S Lit; Bradley S Foster; Erik Kruger; Pravin Dugel; Thomas Chang; Arup Das; Thomas A Ciulla; John S Pollack; Jennifer I Lim; Dean Eliot; Peter A Campochiaro; Dean Eliott
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study.
Ophthalmology 2010;117(11):2146-51.
2010: Raquel Lima e Silva; Jikui Shen; Yuan Yuan Gong; Christopher P Seidel; Sean F Hackett; Kamala Kesavan; Douglas B Jacoby; Peter A Campochiaro
Agents that bind annexin A2 suppress ocular neovascularization.
Journal of cellular physiology 2010;225(3):855-64.
2010: Akiko Miki; Katsuaki Miki; Shinji Ueno; Delphine M Bonnet Wersinger; CYNTHIA BERLINICKE; Gillian C Shaw; Shinichi Usui; Yuxia Wang; Donald J Zack; Peter A Campochiaro
Prolonged blockade of VEGF receptors does not damage retinal photoreceptors or ganglion cells.
Journal of cellular physiology 2010;224(1):262-72.
2010: Peter A Campochiaro; Gulnar Hafiz; Syed Mahmood Shah; Steven Bloom; David M Brown; Miguel Busquets; Thomas Ciulla; Leonard Feiner; Nelson Sabates; Kathleen Billman; Barry Kapik; Ken Green; Frances Kane
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
Ophthalmology 2010;117(7):1393-9.e3.
2010: Peter A Campochiaro; Jeffrey S Heier; Leonard Feiner; Sarah Gray; Namrata Saroj; Amy Chen Rundle; Wendy Yee Murahashi; Roman G Rubio
Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.
Ophthalmology 2010;117(6):1102-1112.e1.
2010: David M Brown; Peter A Campochiaro; Rishi P Singh; Zhengrong Li; Sarah Gray; Namrata Saroj; Amy Chen Rundle; Roman G Rubio; Wendy Yee Murahashi
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.
Ophthalmology 2010;117(6):1124-1133.e1.
2010: Tsunehiko Yoshida; Huafeng Zhang; Takeshi Iwase; Jikui Shen; Gregg L Semenza; Peter A Campochiaro
Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010;24(6):1759-67.
2010: Peter A Campochiaro; Syed Mahmood Shah; Gulnar Hafiz; Jeffery S Heier; Eugene S Lit; Ingrid Zimmer-Galler; Roomasa Channa; Quan Dong Nguyen; Beena Syed; Diana V Do; Lili Lu; James Monk; John P Cooke; M Ken Kengatharan; Henry H Hsu
Topical mecamylamine for diabetic macular edema.
American journal of ophthalmology 2010;149(5):839-51.e1.
2010: Benjamin M Neale; Jesen Fagerness; Robyn Reynolds; Lucia Sobrin; Margaret Parker; Soumya Raychaudhuri; Perciliz L Tan; Edwin C Oh; Joanna E Merriam; Eric Souied; Paul S Bernstein; Binxing Li; Jeanne M Frederick; Kang Zhang; Milam A Brantley; Aaron Y Lee; Donald J Zack; Betsy Campochiaro; Peter A Campochiaro; Stephan Ripke; R Theodore Smith; Gaetano R Barile; Nicholas Katsanis; Rando Allikmets; Mark J Daly; Johanna M Seddon
Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC).
Proceedings of the National Academy of Sciences of the United States of America 2010;107(16):7395-400.
2010: Wei Chen; Dwight Stambolian; Albert O Edwards; Kari E H Branham; Mohammad Othman; Johanna Jakobsdottir; Nirubol Tosakulwong; Margaret Pericak-Vance; Peter A Campochiaro; Michael L Klein; Perciliz L Tan; Yvette P Conley; Atsuhiro Kanda; Laura Kopplin; Yanming Li; Katherine J Augustaitis; Athanasios J Karoukis; William Scott; Anita Agarwal; Jaclyn Kovach; Stephen Schwartz; Eric A Postel; Matthew Brooks; Keith H Baratz; William L Brown; Alexander J Brucker; Anton Orlin; Gary Brown; Allen Ho; Carl Regillo; Larry Donoso; Lifeng Tian; Brian Kaderli; Dexter Hadley; Stephanie A Hagstrom; Neal S Peachey; Ronald Klein; Barbara E K Klein; Gotoh Norimoto; Kenji Yamashiro; Frederick Ferris Iii; Jesen A Fagerness; Robyn Reynolds; Lindsay A Farrer; Ivana K Kim; Joan W Miller; Marta Cortón; Angel Carracedo; Manuel Sanchez-Salorio; Elizabeth W Pugh; Kimberly F Doheny; Maria Brion; Margaret M Deangelis; Daniel E Weeks; Donald J Zack; Emily Y Chew; John R Heckenlively; Nagahisa Yoshimura; Sudha K Iyengar; Peter J Francis; Nicholas Katsanis; Johanna M Seddon; Jonathan L Haines; Michael B Gorin; Gonçalo R Abecasis; Anand Swaroop
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(16):7401-6.
2010: Peter A Campochiaro
The complexity of animal model generation for complex diseases.
JAMA : the journal of the American Medical Association 2010;303(7):657-8.
2010: Zhenglin Yang; Zongzhong Tong; Yuhong Chen; Jiexi Zeng; Fang Lu; Xufang Sun; Chao Zhao; Kevin Wang; Lisa Davey; Haoyu Chen; Nyall London; Daisuke Muramatsu; Francesca Salasar; Ruben Carmona; Daniel Kasuga; Xiaolei Wang; Matthew Bedell; Manjuxia Dixie; Peiquan Zhao; Ruifu Yang; Daniel Gibbs; Xiaoqi Liu; Yan Li; Cai Li; Yuanfeng Li; Betsy Campochiaro; Ryan Constantine; Donald J Zack; Peter A Campochiaro; Yinbin Fu; Dean Y Li; Nicholas Katsanis; Kang Zhang
Genetic and functional dissection of HTRA1 and LOC387715 in age-related macular degeneration.
PLoS genetics 2010;6(2):e1000836.
2009: Quan Dong Nguyen; Syed Mahmood Shah; David J Browning; Henry Hudson; Peter Sonkin; Seenu M Hariprasad; Peter Kaiser; Jason S Slakter; Julia Haller; Diana V Do; William F Mieler; Karen Chu; Ke Yang; Avner Ingerman; Robert L Vitti; Alyson J Berliner; Jesse Cedarbaum; Peter A Campochiaro
A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration.
Ophthalmology 2009;116(11):2141-8.e1.
2009: Peter A Campochiaro; David F Choy; Diana V Do; Gulnar Hafiz; Syed Mahmood Shah; Quan Dong Nguyen; Roman Rubio; Joseph R Arron
Monitoring ocular drug therapy by analysis of aqueous samples.
Ophthalmology 2009;116(11):2158-64.
2009: Quan Dong Nguyen; Syed Mahmood Shah; Jeffery S Heier; Diana V Do; Jennifer I Lim; David Boyer; Prema Abraham; Peter A Campochiaro
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study.
Ophthalmology 2009;116(11):2175-81.e1.
2009: Katsuaki Miki; Akiko Miki; Masato Matsuoka; Daisuke Muramatsu; Sean F Hackett; Peter A Campochiaro
Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor.
Ophthalmology 2009;116(9):1748-54.
2009: Shinichi Usui; Brian C Oveson; Sun Young Lee; Young-Joon Jo; Tsunehiko Yoshida; Akiko Miki; Katsuaki Miki; Takeshi Iwase; Lili Lu; Peter A Campochiaro
NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa.
Journal of neurochemistry 2009;110(3):1028-37.
2009: Aling Dong; Bing Xie; Jikui Shen; Tsunehiko Yoshida; Katsutoshi Yokoi; Sean F Hackett; Peter A Campochiaro
Oxidative stress promotes ocular neovascularization.
Journal of cellular physiology 2009;219(3):544-52.
2009: Shinichi Usui; Keiichi Komeima; Sun Young Lee; Young-Joon Jo; Shinji Ueno; Brian S Rogers; Zhihao Wu; Jikui Shen; Lili Lu; Brian C Oveson; Peter S Rabinovitch; Peter A Campochiaro
Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa.
Molecular therapy : the journal of the American Society of Gene Therapy 2009;17(5):778-86.
2009: Victor Guaiquil; Steven Swendeman; Tsunehiko Yoshida; Sai Chavala; Peter A Campochiaro; Carl P Blobel
ADAM9 is involved in pathological retinal neovascularization.
Molecular and cellular biology 2009;29(10):2694-703.
2009: Kyoichi Takahashi; Yoshitsugu Saishin; Yumiko Saishin; Andrew G King; Robert Levin; Peter A Campochiaro
Suppression and regression of choroidal neovascularization by the multitargeted kinase inhibitor pazopanib.
Archives of ophthalmology 2009;127(4):494-9.
2009: Lili Lu; Brain C Oveson; Young-Joon Jo; Thomas W Lauer; Shinichi Usui; Keiichi Komeima; Bing Xie; Peter A Campochiaro
Increased expression of glutathione peroxidase 4 strongly protects retina from oxidative damage.
Antioxidants & redox signaling 2009;11(4):715-24.
2009: Diana V Do; Quan Dong Nguyen; Syed Mahmood Shah; D J Browning; J A Haller; K Chu; K Yang; Jesse Cedarbaum; R L Vitti; A Ingerman; Peter A Campochiaro
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema.
The British journal of ophthalmology 2009;93(2):144-9.
2009: Shu Kachi; Katie Binley; Katsutoshi Yokoi; Naoyasu Umeda; Hideo Akiyama; Daisuke Muramatu; Sharifah Iqball; On Kan; Stuart Naylor; Peter A Campochiaro
Equine infectious anemia viral vector-mediated codelivery of endostatin and angiostatin driven by retinal pigmented epithelium-specific VMD2 promoter inhibits choroidal neovascularization.
Human gene therapy 2009;20(1):31-9.
2009: Noriko Esumi; Shu Kachi; Laszlo Hackler; Tomohiro Masuda; Zhiyong Yang; Peter A Campochiaro; Donald J Zack
BEST1 expression in the retinal pigment epithelium is modulated by OTX family members.
Human molecular genetics 2009;18(1):128-41.
2009: Bing Xie; Jikui Shen; Aling Dong; Aymen Rashid; Glenn Stoller; Peter A Campochiaro
Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization.
Journal of cellular physiology 2009;218(1):192-8.
2008: Zhenglin Yang; Charity Stratton; Peter J Francis; Mark E Kleinman; Perciliz L Tan; Daniel Gibbs; Zongzhong Tong; Haoyu Chen; Ryan Constantine; Xian Yang; Yuhong Chen; Jiexi Zeng; Lisa Davey; Xiang Ma; Vincent S Hau; Chi Wang; Jennifer Harmon; Jeanette Buehler; Erik Pearson; Shrena Patel; Yuuki Kaminoh; Scott Watkins; Ling Luo; Norman A Zabriskie; Paul S Bernstein; Wongil Cho; Andrea Schwager; David R Hinton; Michael L Klein; Sara C Hamon; Emily Simmons; Beifeng Yu; Betsy Campochiaro; Janet S Sunness; Peter A Campochiaro; Lynn Jorde; Giovanni Parmigiani; Donald J Zack; Nicholas Katsanis; Jayakrishna Ambati; Kang Zhang
Toll-like receptor 3 and geographic atrophy in age-related macular degeneration.
The New England journal of medicine 2008;359(14):1456-63.
2008: Shinji Ueno; Mary Ellen Pease; Delphine M Bonnet Wersinger; Tomohiro Masuda; Stanley A Vinores; Tamar Licht; Donald J Zack; Harry A Quigley; Eli Keshet; Peter A Campochiaro
Prolonged blockade of VEGF family members does not cause identifiable damage to retinal neurons or vessels.
Journal of cellular physiology 2008;217(1):13-22.
2008: Keiichi Komeima; Shinichi Usui; Jikui Shen; Brian S Rogers; Peter A Campochiaro
Blockade of neuronal nitric oxide synthase reduces cone cell death in a model of retinitis pigmentosa.
Free radical biology & medicine 2008;45(6):905-12.
2008: Bing Xie; Jikui Shen; Aling Dong; Mara Swaim; Sean F Hackett; Lorenza Wyder; Susanne Worpenberg; Samuel Barbieri; Peter A Campochiaro
An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(8):2775-83.
2008: Jikui Shen; Xiaoru Yang; Bing Xie; Yangjian Chen; Mara Swaim; Sean F Hackett; Peter A Campochiaro
MicroRNAs regulate ocular neovascularization.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(7):1208-16.
2008: John Doukas; Sankaranarayana Mahesh; Naoyasu Umeda; Shu Kachi; Hideo Akiyama; Katsutoshi Yokoi; Jon Cao; Zoe Chen; Luis Dellamary; Betty Tam; Adrienne Racanelli-Layton; John Hood; Michael Martin; Glenn Noronha; Richard Soll; Peter A Campochiaro
Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema.
Journal of cellular physiology 2008;216(1):29-37.
2008: Katsuji Kiuchi; Masato Matsuoka; Jenny C Wu; Raquel Lima e Silva; Muralitharan Kengatharan; Mary Verghese; Shinji Ueno; Katsutoshi Yokoi; Naw Htee Khu; john cooke; Peter A Campochiaro
Mecamylamine suppresses Basal and nicotine-stimulated choroidal neovascularization.
Investigative ophthalmology & visual science 2008;49(4):1705-11.
2008: Peter A Campochiaro; Gulnar Hafiz; Syed Mahmood Shah; Quan Dong Nguyen; Howard S Ying; Diana V Do; Edward Quinlan; Ingrid Zimmer-Galler; Julia A Haller; Sharon D Solomon; Jennifer U Sung; Yasmin Hadi; Kashif A Janjua; Nida Jawed; David F Choy; Joseph R Arron
Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(4):791-9.
2008: Moorthy S S Palanki; Hideo Akiyama; Peter A Campochiaro; Jianguo Cao; Chun P Chow; Luis Dellamary; John Doukas; Richard Fine; Colleen Gritzen; John Hood; Steven Hu; Shu Kachi; Xinshan Kang; Boris Klebansky; Ahmed Kousba; Dan Lohse; Chi Ching Mak; Michael Martin; Andrew McPherson; Ved P Pathak; Joel Renick; Richard Soll; Naoyasu Umeda; Shiyin Yee; Katsutoshi Yokoi; Binqi Zeng; Hong Zhu; Glenn Noronha
Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration.
Journal of medicinal chemistry 2008;51(6):1546-59.
2008: Anna Maria Demetriades; Tye Deering; Hansheng Liu; Lili Lu; Peter L Gehlbach; Jonathan D Packer; Feilim Mac Gabhann; Aleksander S Popel; Lisa L Wei; Peter A Campochiaro
Trans-scleral delivery of antiangiogenic proteins.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2008;24(1):70-9.
2008: Quan Dong Nguyen; Syed Mahmood Shah; Gulnar Hafiz; Diana V Do; Julia A Haller; Roberto Pili; Ingrid Zimmer-Galler; Kashif Janjua; R C Andrew Symons; Peter A Campochiaro
Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration.
American journal of ophthalmology 2008;145(2):257-266.
2007: Jikui Shen; Aling Dong; Sean F Hackett; William R Bell; W Richard Green; Peter A Campochiaro
Oxidative damage in age-related macular degeneration.
Histology and histopathology 2007;22(12):1301-8.
2007: Keiichi Komeima; Brian S Rogers; Peter A Campochiaro
Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa.
Journal of cellular physiology 2007;213(3):809-15.
2007: Aling Dong; Jikui Shen; Melissa Krause; Sean F Hackett; Peter A Campochiaro
Increased expression of glial cell line-derived neurotrophic factor protects against oxidative damage-induced retinal degeneration.
Journal of neurochemistry 2007;103(3):1041-52.
2007: Nicola G Ghazi; Jessica B Ciralsky; Syed Mahmood Shah; Peter A Campochiaro; Julia A Haller
Optical coherence tomography findings in persistent diabetic macular edema: the vitreomacular interface.
American journal of ophthalmology 2007;144(5):747-754.
2007: Katsutoshi Yokoi; Huanda Steve Zhang; Shu Kachi; Kamaljit S Balaggan; Qi Yu; Dmitry Guschin; Mike Kunis; Richard Surosky; Liza M Africa; J W B Bainbridge; S Kaye Spratt; Philip D Gregory; Robin R Ali; Peter A Campochiaro
Gene transfer of an engineered zinc finger protein enhances the anti-angiogenic defense system.
Molecular therapy : the journal of the American Society of Gene Therapy 2007;15(11):1917-23.
2007: Jikui Shen; Bing Xie; Christina M Hatara; Sean F Hackett; Peter A Campochiaro
Vegf or EphA2 antisense polyamide-nucleic acids; vascular localization and suppression of retinal neovascularization.
Molecular therapy : the journal of the American Society of Gene Therapy 2007;15(11):1924-30.
2007: Peter A Campochiaro
Seeing the light: new insights into the molecular pathogenesis of retinal diseases.
Journal of cellular physiology 2007;213(2):348-54.
2007: Raquel Lima e Silva; Jikui Shen; Sean F Hackett; Shu Kachi; Hideo Akiyama; Katsuji Kiuchi; Katsutoshi Yokoi; Maria C Hatara; Thomas W Lauer; Sadia Aslam; Yuan Yuan Gong; Wei-Hong Xiao; Naw Htee Khu; Catherine Thut; Peter A Campochiaro
The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(12):3219-30.
2007: Jikui Shen; Bing Xie; Aling Dong; Mara Swaim; Sean F Hackett; Peter A Campochiaro
In vivo immunostaining demonstrates macrophages associate with growing and regressing vessels.
Investigative ophthalmology & visual science 2007;48(9):4335-41.
2007: Zhihao Wu; Thomas W Lauer; Anna Sick; Sean F Hackett; Peter A Campochiaro
Oxidative stress modulates complement factor H expression in retinal pigmented epithelial cells by acetylation of FOXO3.
The Journal of biological chemistry 2007;282(31):22414-25.
2007: Peter A Campochiaro
Targeted pharmacotherapy of retinal diseases with ranibizumab.
Drugs of today (Barcelona, Spain : 1998) 2007;43(8):529-37.
2007: Katsutoshi Yokoi; Shu Kachi; H Steve Zhang; Philip D Gregory; S Kaye Spratt; R Jude Samulski; Peter A Campochiaro
Ocular gene transfer with self-complementary AAV vectors.
Investigative ophthalmology & visual science 2007;48(7):3324-8.
2007: Diana V Do; Minhee Cho; Quan Dong Nguyen; Syed Mahmood Shah; James T Handa; Peter A Campochiaro; Ingrid Zimmer-Galler; Jennifer U Sung; Julia A Haller
Impact of optical coherence tomography on surgical decision making for epiretinal membranes and vitreomacular traction.
Retina (Philadelphia, Pa.) 2007;27(5):552-6.
2007: Feilim Mac Gabhann; Anna Maria Demetriades; Tye Deering; Jonathan D Packer; Syed Mahmood Shah; Elia J Duh; Peter A Campochiaro; Aleksander S Popel
Protein transport to choroid and retina following periocular injection: theoretical and experimental study.
Annals of biomedical engineering 2007;35(4):615-30.
2007: Peter A Campochiaro
Molecular targets for retinal vascular diseases.
Journal of cellular physiology 2007;210(3):575-81.
2007: Peter A Campochiaro
Gene therapy for ocular neovascularization.
Current gene therapy 2007;7(1):25-33.
2007: Noriko Esumi; Shu Kachi; Peter A Campochiaro; Donald J Zack
VMD2 promoter requires two proximal E-box sites for its activity in vivo and is regulated by the MITF-TFE family.
The Journal of biological chemistry 2007;282(3):1838-50.
2007: Sinan Tatlipinar; Syed Mahmood Shah; Peter A Campochiaro; Quan Dong Nguyen
Intraobserver repeatability of automated versus adjusted optical coherence tomography measurements in patients with neovascular age-related macular degeneration.
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde 2007;221(4):227-32.
2007: Brian S Rogers; Robert C A Symons; Keiichi Komeima; Jikui Shen; Weihong Xiao; Mara E Swaim; Yuan Yuan Gong; Shu Kachi; Peter A Campochiaro
Differential sensitivity of cones to iron-mediated oxidative damage.
Investigative ophthalmology & visual science 2007;48(1):438-45.
2007: Stanley A Vinores; Wei-Hong Xiao; Jikui Shen; Peter A Campochiaro
TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage.
Journal of neuroimmunology 2007;182(1-2):73-9.
2006: Syed Mahmood Shah; Sinan Tatlipinar; Edward Quinlan; Jennifer U Sung; Homaoun Tabandeh; Quan Dong Nguyen; Ahmed S Fahmy; Ingrid Zimmer-Galler; R C Andrew Symons; Jesse Cedarbaum; Peter A Campochiaro
Dynamic and quantitative analysis of choroidal neovascularization by fluorescein angiography.
Investigative ophthalmology & visual science 2006;47(12):5460-8.
2006: Quan Dong Nguyen; Sinan Tatlipinar; Syed Mahmood Shah; Julia A Haller; Edward Quinlan; Jennifer U Sung; Ingrid Zimmer-Galler; Diana V Do; Peter A Campochiaro
Vascular endothelial growth factor is a critical stimulus for diabetic macular edema.
American journal of ophthalmology 2006;142(6):961-9.
2006: Zhihao Wu; Brian Rogers; Shu Kachi; Sean F Hackett; Anna Sick; Peter A Campochiaro
Reduction of p66Shc suppresses oxidative damage in retinal pigmented epithelial cells and retina.
Journal of cellular physiology 2006;209(3):996-1005.
2006: Raquel Lima e Silva; Shu Kachi; Hideo Akiyama; Jikui Shen; Maria C Hatara; Sadia Aslam; Yuan Yuan Gong; Naw Htee Khu; Thomas W Lauer; Sean F Hackett; Laurence J Marton; Peter A Campochiaro
Trans-scleral delivery of polyamine analogs for ocular neovascularization.
Experimental eye research 2006;83(5):1260-7.
2006: Ricardo A Pontes de Carvalho; Melissa L Krausse; A Linn Murphree; Edward E Schmitt; Peter A Campochiaro; Irene H Maumenee
Delivery from episcleral exoplants.
Investigative ophthalmology & visual science 2006;47(10):4532-9.
2006: Michael Lochrie; Gwen P Tatsuno; Alejandra E Arbetman; Kris Jones; Cheryl Pater; Peter H Smith; Jennifer W McDonnell; Shang-Zhen Zhou; Shu Kachi; Michiko Kachi; Peter A Campochiaro; Glenn F Pierce; Peter Colosi
Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5.
Virology 2006;353(1):68-82.
2006: Quan Dong Nguyen; Syed Mahmood Shah; Gulnar Hafiz; Edward Quinlan; Jennifer U Sung; Karen Chu; Jesse Cedarbaum; Peter A Campochiaro
A phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degeneration.
Ophthalmology 2006;113(9):1522.e1-1522.e14.
2006: Aling Dong; Jikui Shen; Melissa Krause; Hideo Akiyama; Sean F Hackett; Hong Lai; Peter A Campochiaro
Superoxide dismutase 1 protects retinal cells from oxidative damage.
Journal of cellular physiology 2006;208(3):516-26.
2006: Keiichi Komeima; Brian S Rogers; Lili Lu; Peter A Campochiaro
Antioxidants reduce cone cell death in a model of retinitis pigmentosa.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(30):11300-5.
2006: Raquel Lima e Silva; Shu Kachi; Hideo Akiyama; Jikui Shen; Sadia Aslam; Yuan Yuan Gong; Naw Htee Khu; Maria C Hatara; Ariel Boutaud; Robert Peterson; Peter A Campochiaro
Recombinant non-collagenous domain of alpha2(IV) collagen causes involution of choroidal neovascularization by inducing apoptosis.
Journal of cellular physiology 2006;208(1):161-6.
2006: Naoyasu Umeda; Shu Kachi; Hideo Akiyama; Grit Zahn; Dörte Vossmeyer; Roland Stragies; Peter A Campochiaro
Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonist.
Molecular pharmacology 2006;69(6):1820-8.
2006: Itay Chowers; Robert Wong; Tzvete Dentchev; Ronald H Farkas; Jared Iacovelli; Tushara L Gunatilaka; Nancy E Medeiros; J Brett Presley; Peter A Campochiaro; Christine A Curcio; Joshua L Dunaief; Donald J Zack
The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration.
Investigative ophthalmology & visual science 2006;47(5):2135-40.
2006: Shu Kachi; Noriko Esumi; Donald J Zack; Peter A Campochiaro
Sustained expression after nonviral ocular gene transfer using mammalian promoters.
Gene therapy 2006;13(9):798-804.
2006: Hideo Akiyama; Shu Kachi; Raquel Lima Silva; Naoyasu Umeda; Sean F Hackett; Dilara McCauley; Thomas G McCauley; Anna J Zoltoski; David M Epstein; Peter A Campochiaro
Intraocular injection of an aptamer that binds PDGF-B: a potential treatment for proliferative retinopathies.
Journal of cellular physiology 2006;207(2):407-12.
2006: Jikui Shen; XiaoRu Yang; Wei-Hong Xiao; Sean F Hackett; Yasufumi Sato; Peter A Campochiaro
Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(6):723-5.
2006: Stanley A Vinores; Wei-Hong Xiao; Sadia Aslam; Jikui Shen; Yuji Oshima; Hiroyuki Nambu; Hansheng Liu; Peter Carmeliet; Peter A Campochiaro
Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development.
Journal of cellular physiology 2006;206(3):749-58.
2006: Peter A Campochiaro
Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders.
Gene therapy 2006;13(6):559-62.
2006: Celia Cingolani; Brian Rogers; Lili Lu; Shu Kachi; Jikui Shen; Peter A Campochiaro
Retinal degeneration from oxidative damage.
Free radical biology & medicine 2006;40(4):660-9.
2006: Peter A Campochiaro; Quan Dong Nguyen; Syed Mahmood Shah; Michael L Klein; Eric Holz; Robert N Frank; David A Saperstein; Anurag Gupta; J Timothy Stout; Jennifer Macko; Robert DiBartolomeo; Lisa L Wei
Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial.
Human gene therapy 2006;17(2):167-76.
2006: Peter A Campochiaro
Ocular versus extraocular neovascularization: mirror images or vague resemblances.
Investigative ophthalmology & visual science 2006;47(2):462-74.
2006: Jikui Shen; Rebecca Samul; Raquel Lima Silva; Hideo Akiyama; Hansheng Liu; Yoshitsugu Saishin; Sean F Hackett; Shawn Zinnen; K Kossen; K Fosnaugh; Chandra Vargeese; A Gomez; K Bouhana; R Aitchison; PA Pavco; Peter A Campochiaro
Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1.
Gene therapy 2006;13(3):225-34.
2006: Diana V Do; Minhee Cho; Quan Dong Nguyen; Syed Mahmood Shah; James T Handa; Peter A Campochiaro; Ingrid Zimmer-Galler; Jennifer U Sung; Julia A Haller
The impact of optical coherence tomography on surgical decision making in epiretinal membrane and vitreomacular traction.
Transactions of the American Ophthalmological Society 2006;104():161-6.
2006: Lili Lu; Sean F Hackett; Andrew Mincey; Hong Lai; Peter A Campochiaro
Effects of different types of oxidative stress in RPE cells.
Journal of cellular physiology 2006;206(1):119-25.
2005: Hideo Akiyama; Khalid A Mohamedali; Raquel Lima E Silva; Shu Kachi; Jikui Shen; Christina Hatara; Naoyasu Umeda; Sean F Hackett; Sadia Aslam; Melissa Krause; Hong Lai; Michael G Rosenblum; Peter A Campochiaro
Vascular targeting of ocular neovascularization with a vascular endothelial growth factor121/gelonin chimeric protein.
Molecular pharmacology 2005;68(6):1543-50.
2005: Quan Dong Nguyen; Syed Mahmood Shah; Sinan Tatlipinar; Diana V Do; E V Anden; Peter A Campochiaro
Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia.
The British journal of ophthalmology 2005;89(10):1368-70.
2005: Raquel Lima e Silva; Yoshitsugu Saishin; Yumiko Saishin; Hideo Akiyama; Shu Kachi; Sadia Aslam; Brian Rogers; Tye Deering; Yuan Yuan Gong; Sean F Hackett; Hong Lai; Benjamin Frydman; Aldonia Valasinas; Laurence J Marton; Peter A Campochiaro
Suppression and regression of choroidal neovascularization by polyamine analogues.
Investigative ophthalmology & visual science 2005;46(9):3323-30.
2005: Hiroyuki Nambu; Naoyasu Umeda; Shu Kachi; Yuji Oshima; Hideo Akiyama; Rie Nambu; Peter A Campochiaro
Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization.
Journal of cellular physiology 2005;204(1):227-35.
2005: Yuji Oshima; Sachiko Oshima; Hiroyuki Nambu; Shu Kachi; Kyoichi Takahashi; Naoyasu Umeda; Jikui Shen; Aling Dong; Rajendra S Apte; Elia J Duh; Sean F Hackett; Godwin Okoye; Kazuki Ishibashi; James T Handa; Michele Melia; Stanley J Wiegand; George D Yancopoulos; Donald J Zack; Peter A Campochiaro
Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(8):963-5.
2005: Jikui Shen; Xiaoru Yang; Aling Dong; Robert M Petters; You-Wei Peng; Fulton Wong; Peter A Campochiaro
Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa.
Journal of cellular physiology 2005;203(3):457-64.
2005: Shu Kachi; Y Oshima; Noriko Esumi; M Kachi; Brian Rogers; Donald J Zack; Peter A Campochiaro
Nonviral ocular gene transfer.
Gene therapy 2005;12(10):843-51.
2005: Yoshitsugu Saishin; Raquel Lima Silva; Yumiko Saishin; Shu Kachi; Sadia Aslam; Yuan Yuan Gong; Hong Lai; Miguel Carrion; Brent Harris; Melissa Hamilton; Lisa Wei; Peter A Campochiaro
Periocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eye.
Human gene therapy 2005;16(4):473-8.
2004: Yuji Oshima; Sachiko Oshima; Hiroyuki Nambu; Shu Kachi; Sean F Hackett; Michele Melia; Michael Kaleko; Sheila Connelly; Noriko Esumi; Donald J Zack; Peter A Campochiaro
Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization.
Journal of cellular physiology 2004;201(3):393-400.
2004: Peter A Campochiaro
Ocular neovascularisation and excessive vascular permeability.
Expert opinion on biological therapy 2004;4(9):1395-402.
2004: Abigail S Hackam; Richelle Strom; Dongmei Liu; Jiang Qian; Chenwei Wang; Deborah C Otteson; Tushara L Gunatilaka; Ronald H Farkas; Itay Chowers; Masaaki Kageyama; Thierry Leveillard; José-Alain Sahel; Peter A Campochiaro; Giovanni Parmigiani; Donald J Zack
Identification of gene expression changes associated with the progression of retinal degeneration in the rd1 mouse.
Investigative ophthalmology & visual science 2004;45(9):2929-42.
2004: Itay Chowers; Yoonhee Kim; Ronald H Farkas; Tushara L Gunatilaka; Abigail S Hackam; Peter A Campochiaro; Silvia C Finnemann; Donald J Zack
Changes in retinal pigment epithelial gene expression induced by rod outer segment uptake.
Investigative ophthalmology & visual science 2004;45(7):2098-106.
2004: Karl Wahlin; Lynette Lim; Elizabeth A Grice; Peter A Campochiaro; Donald J Zack; Ruben Adler
A method for analysis of gene expression in isolated mouse photoreceptor and Müller cells.
Molecular vision 2004;10():366-75.
2004: Hansheng Liu; Anna Maria Demetriades; Wei-Hong Xiao; Peter A Campochiaro; Stanley A Vinores
Mouse model of post-surgical breakdown of the blood-retinal barrier.
Current eye research 2004;28(6):421-6.
2004: Yuji Oshima; Tye Deering; Sachiko Oshima; Hiroyuki Nambu; P Seshidhar Reddy; Michael Kaleko; Sheila Connelly; Sean F Hackett; Peter A Campochiaro
Angiopoietin-2 enhances retinal vessel sensitivity to vascular endothelial growth factor.
Journal of cellular physiology 2004;199(3):412-7.
2004: Yuji Oshima; Kyoichi Takahashi; Sachiko Oshima; Yoshitsugu Saishin; Yumiko Saishin; Raquel Lima Silva; Xaoling Liang; P Seshidhar Reddy; Shanthi Ganesh; Terrence Brann; Gene Liau; Michael Kaleko; Sheila Connelly; Peter A Campochiaro
Intraocular gutless adenoviral-vectored VEGF stimulates anterior segment but not retinal neovascularization.
Journal of cellular physiology 2004;199(3):399-411.
2004: Hiroyuki Nambu; Rie Nambu; Yuji Oshima; Sean F Hackett; Godwin Okoye; Stanley J Wiegand; George D Yancopoulos; Donald J Zack; Peter A Campochiaro
Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier.
Gene therapy 2004;11(10):865-73.
2004: Noriko Esumi; Yuji Oshima; Yuanyuan Li; Peter A Campochiaro; Donald J Zack
Analysis of the VMD2 promoter and implication of E-box binding factors in its regulation.
The Journal of biological chemistry 2004;279(18):19064-73.
2004: Elia J Duh; Hoseong S Yang; Julia A Haller; Eugene de JUAN; Mark S Humayun; Peter L Gehlbach; Michele Melia; Dante J Pieramici; JOSEPH HARLAN; Peter A Campochiaro; Donald J Zack
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
American journal of ophthalmology 2004;137(4):668-74.
2004: Peter A Campochiaro
Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412.
Investigative ophthalmology & visual science 2004;45(3):922-31.
2004: Quan Dong Nguyen; Syed Mahmood Shah; Elizabeth Van Anden; Jennifer U Sung; Susan Vitale; Peter A Campochiaro
Supplemental oxygen improves diabetic macular edema: a pilot study.
Investigative ophthalmology & visual science 2004;45(2):617-24.
2004: Jikui Shen; Rebecca Samul; Joelle Zimmer; Hansheng Liu; Xiaoling Liang; Sean F Hackett; Peter A Campochiaro
Deficiency of neuropilin 2 suppresses VEGF-induced retinal neovascularization.
Molecular medicine (Cambridge, Mass.) 2004;10(1-6):12-8.
2004: Itay Chowers; Noriko Esumi; Peter A Campochiaro; Donald J Zack
Studies on retinal and retinal pigment epithelial gene expression.
Novartis Foundation symposium 2004;255():131-45; discussion 145-6, 177-8.
2003: Hisashi Ida; Takao Tobe; Hiroyuki Nambu; Miyo Matsumura; Masanobu Uyama; Peter A Campochiaro
RPE cells modulate subretinal neovascularization, but do not cause regression in mice with sustained expression of VEGF.
Investigative ophthalmology & visual science 2003;44(12):5430-7.
2003: Brian D Kelly; Sean F Hackett; Kiichi Hirota; Yuji Oshima; Zheqing Cai; Shannon Berg-Dixon; Ashley Rowan; Zhijiang Yan; Peter A Campochiaro; Gregg L Semenza
Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1.
Circulation research 2003;93(11):1074-81.
2003: Itay Chowers; Dongmei Liu; Ronald H Farkas; Tushara L Gunatilaka; Abigail S Hackam; Steven L Bernstein; Peter A Campochiaro; Giovanni Parmigiani; Donald J Zack
Gene expression variation in the adult human retina.
Human molecular genetics 2003;12(22):2881-93.
2003: Yoshitsugu Saishin; Raquel Lima Silva; Yumiko Saishin; Kevin Callahan; Christian Schoch; Markus Ahlheim; Hong Lai; Frances Kane; R K Brazzell; David Bodmer; Peter A Campochiaro
Periocular injection of microspheres containing PKC412 inhibits choroidal neovascularization in a porcine model.
Investigative ophthalmology & visual science 2003;44(11):4989-93.
2003: Peter A Campochiaro; Sean F Hackett
Ocular neovascularization: a valuable model system.
Oncogene 2003;22(42):6537-48.
2003: Itay Chowers; Tushara L Gunatilaka; Ronald H Farkas; Jiang Qian; Abigail S Hackam; Elia J Duh; Masaaki Kageyama; Chenwei Wang; Amit Vora; Peter A Campochiaro; Donald J Zack
Identification of novel genes preferentially expressed in the retina using a custom human retina cDNA microarray.
Investigative ophthalmology & visual science 2003;44(9):3732-41.
2003: Yoshitsugu Saishin; Yumiko Saishin; Kyoichi Takahashi; Man-Seong Seo; Michele Melia; Peter A Campochiaro
The kinase inhibitor PKC412 suppresses epiretinal membrane formation and retinal detachment in mice with proliferative retinopathies.
Investigative ophthalmology & visual science 2003;44(8):3656-62.
2003: Hiroyuki Nambu; Rie Nambu; Michele Melia; Peter A Campochiaro
Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularization.
Investigative ophthalmology & visual science 2003;44(8):3650-5.
2003: Godwin Okoye; Joelle Zimmer; Jennifer U Sung; Peter L Gehlbach; Tye Deering; Hiroyuki Nambu; Sean F Hackett; Michele Melia; Noriko Esumi; Donald J Zack; Peter A Campochiaro
Increased expression of brain-derived neurotrophic factor preserves retinal function and slows cell death from rhodopsin mutation or oxidative damage.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(10):4164-72.
2003: Kyoichi Takahashi; Yoshitsugu Saishin; Yumiko Saishin; Raquel Lima Silva; Yuji Oshima; Sachiko Oshima; Michele Melia; Brian Paszkiet; Dennis Zerby; Michael J Kadan; Gene Liau; Michael Kaleko; Sheila Connelly; Tianci Luo; Peter A Campochiaro
Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(8):896-8.
2003: Yoshitsugu Saishin; Yumiko Saishin; Kyoichi Takahashi; Raquel Lima e Silva; Donna Hylton; John S Rudge; Stanley J Wiegand; Peter A Campochiaro
VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.
Journal of cellular physiology 2003;195(2):241-8.
2003: Yoshitsugu Saishin; Yumiko Saishin; Kyoichi Takahashi; Michele Melia; Stanley A Vinores; Peter A Campochiaro
Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier.
Journal of cellular physiology 2003;195(2):210-9.
2003: Peter L Gehlbach; Anna Maria Demetriades; Satoru Yamamoto; Tye Deering; Elia J Duh; Hoseong S Yang; C Cingolani; Hong Lai; Lisa Wei; Peter A Campochiaro
Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization.
Gene therapy 2003;10(8):637-46.
2003: Anna-Maria Demetriades; John D Gottsch; Robert W Thomsen; Amr Azab; Walter J Stark; Peter A Campochiaro; Eugene de JUAN; Julia A Haller
Combined phacoemulsification, intraocular lens implantation, and vitrectomy for eyes with coexisting cataract and vitreoretinal pathology.
American journal of ophthalmology 2003;135(3):291-6.
2003: Stanley A Vinores; Man-Seong Seo; Nancy L Derevjanik; Peter A Campochiaro
Photoreceptor-specific overexpression of platelet-derived growth factor induces proliferation of endothelial cells, pericytes, and glial cells and aberrant vascular development: an ultrastructural and immunocytochemical study.
Brain research. Developmental brain research 2003;140(2):169-83.
2003: Sharon Fekrat; Marta J Marsh; Sarah H Elsing; Sharath C Raja; Eugene de JUAN; Peter A Campochiaro; Julia A Haller
Intraoperative ketorolac and eye pain after viteoretinal surgery: a prospective, randomized, placebo-controlled study.
Retina (Philadelphia, Pa.) 2003;23(1):8-13.
2003: Michael J Pianta; Tomas S Aleman; Artur Vahe Cideciyan; Janet S Sunness; Yuanyuan Li; Betsy A Campochiaro; Peter A Campochiaro; Donald J Zack; Edwin M Stone; Samuel G Jacobson
In vivo micropathology of Best macular dystrophy with optical coherence tomography.
Experimental eye research 2003;76(2):203-11.
2003: Peter L Gehlbach; Anna Maria Demetriades; Satoru Yamamoto; Tye Deering; Wei-Hong Xiao; Elia J Duh; Hoseong S Yang; Hong Lai; Imre Kovesdi; Miguel Carrion; Lisa Wei; Peter A Campochiaro
Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier.
Human gene therapy 2003;14(2):129-41.
2003: Kyoichi Takahashi; Yoshitsugu Saishin; Yumiko Saishin; Keisuke Mori; Akira Ando; Satoru Yamamoto; Yuji Oshima; Hiroyuki Nambu; Michele Melia; David P Bingaman; Peter A Campochiaro
Topical nepafenac inhibits ocular neovascularization.
Investigative ophthalmology & visual science 2003;44(1):409-15.
2002: nicholas gale; Gavin Thurston; Sean F Hackett; Roumiana Renard; Quan Wang; Joyce McClain; Cliff Martin; Charles L Witte; Marlys H Witte; David Jackson; Chitra Suri; Peter A Campochiaro; Stanley J Wiegand; George D Yancopoulos
Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.
Developmental cell 2002;3(3):411-23.
2002: Akira Ando; Amy Yang; Hiroyuki Nambu; Peter A Campochiaro
Blockade of nitric-oxide synthase reduces choroidal neovascularization.
Molecular pharmacology 2002;62(3):539-44.
2002: Antonio Polito; Syed Mahmood Shah; Julia A Haller; Ingrid Zimmer-Galler; Ran Zeimer; Peter A Campochiaro; Susan Vitale
Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease.
American journal of ophthalmology 2002;134(2):240-51.
2002: Sean F Hackett; Stanley J Wiegand; George D Yancopoulos; Peter A Campochiaro
Angiopoietin-2 plays an important role in retinal angiogenesis.
Journal of cellular physiology 2002;192(2):182-7.
2002: Kyoichi Takahashi; Tianci Luo; Yoshitsugu Saishin; Yumiko Saishin; Jennifer U Sung; Sean F Hackett; R K Brazzell; Michael Kaleko; Peter A Campochiaro
Sustained transduction of ocular cells with a bovine immunodeficiency viral vector.
Human gene therapy 2002;13(11):1305-16.
2002: Shiwani Sharma; Jinghua T Chang; Neil G Della; Peter A Campochiaro; Donald J Zack
Identification of novel bovine RPE and retinal genes by subtractive hybridization.
Molecular vision 2002;8():251-8.
2002: Nancy L Derevjanik; Stanley A Vinores; Wei-Hong Xiao; Keisuke Mori; Tara Turon; Tyler Hudish; Steve Dong; Peter A Campochiaro
Quantitative assessment of the integrity of the blood-retinal barrier in mice.
Investigative ophthalmology & visual science 2002;43(7):2462-7.
2002: Keisuke Mori; Peter L Gehlbach; Akira Ando; Duncan McVey; Lisa Wei; Peter A Campochiaro
Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.
Investigative ophthalmology & visual science 2002;43(7):2428-34.
2002: Peter A Campochiaro
Gene therapy for retinal and choroidal diseases.
Expert opinion on biological therapy 2002;2(5):537-44.
2002: Keisuke Mori; Peter L Gehlbach; Akira Ando; Gawain Dyer; Evan Lipinsky; Aneeka G Chaudhry; Sean F Hackett; Peter A Campochiaro
Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy.
Investigative ophthalmology & visual science 2002;43(6):2001-6.
2002: Keisuke Mori; Peter L Gehlbach; Satoru Yamamoto; Elia J Duh; Donald J Zack; Quihong Li; Kenneth I Berns; Brian J Raisler; William W Hauswirth; Peter A Campochiaro
AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.
Investigative ophthalmology & visual science 2002;43(6):1994-2000.
2002: Keisuke Mori; Peter L Gehlbach; Akira Ando; Karl Wahlin; Vicky Gunther; Duncan McVey; Lisa Wei; Peter A Campochiaro
Intraocular adenoviral vector-mediated gene transfer in proliferative retinopathies.
Investigative ophthalmology & visual science 2002;43(5):1610-5.
2002: Akira Ando; Amy Yang; Keisuke Mori; Haruhiko Yamada; Eri Yamada; Kyoichi Takahashi; Jina Saikia; Min Kim; Michele Melia; Mark Fishman; Paul Huang; Peter A Campochiaro
Nitric oxide is proangiogenic in the retina and choroid.
Journal of cellular physiology 2002;191(1):116-24.
2002: Elia J Duh; Hoseong S Yang; Izumi Suzuma; Masaru Miyagi; Elaine Youngman; Keisuke Mori; Miyuki Katai; Lin Yan; Kiyoshi Suzuma; Karen West; Shekar Davarya; Patrick Tong; Peter L Gehlbach; Joel R Pearlman; John W Crabb; Lloyd Paul Aiello; Peter A Campochiaro; Donald J Zack
Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
Investigative ophthalmology & visual science 2002;43(3):821-9.
2002: Kyoko Ohno-Matsui; Akira Hirose; Satoru Yamamoto; Jina Saikia; Naoyuki Okamoto; Peter L Gehlbach; Elia J Duh; Sean F Hackett; Michelle Chang; Dean Bok; Donald J Zack; Peter A Campochiaro
Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment.
The American journal of pathology 2002;160(2):711-9.
2001: Karl Wahlin; Ruben Adler; Donald J Zack; Peter A Campochiaro
Neurotrophic signaling in normal and degenerating rodent retinas.
Experimental eye research 2001;73(5):693-701.
2001: Howard Rasmussen; K W Chu; Peter A Campochiaro; Peter L Gehlbach; Julia A Haller; James T Handa; Quan Dong Nguyen; Jennifer U Sung
Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
Human gene therapy 2001;12(16):2029-32.
2001: Haruhiko Yamada; Eri Yamada; Akira Ando; Noriko Esumi; N Bora; Jina Saikia; C H Sung; Donald J Zack; Peter A Campochiaro
Fibroblast growth factor-2 decreases hyperoxia-induced photoreceptor cell death in mice.
The American journal of pathology 2001;159(3):1113-20.
2001: Keisuke Mori; Elia J Duh; Peter L Gehlbach; Akira Ando; Kyoichi Takahashi; Joel R Pearlman; K Mori; Hoseong S Yang; Donald J Zack; Damodar Ettyreddy; Douglas E Brough; Lisa L Wei; Peter A Campochiaro
Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.
Journal of cellular physiology 2001;188(2):253-63.
2001: Keisuke Mori; Akira Ando; Peter L Gehlbach; D Nesbitt; Kyoichi Takahashi; Donna Lee Goldsteen; M Penn; C T Chen; K Mori; Michele Melia; Sandrina Phipps; D Moffat; K Brazzell; Gene Liau; K H Dixon; Peter A Campochiaro
Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin.
The American journal of pathology 2001;159(1):313-20.
2001: W Yan; G F Jang; Francoise Haeseleer; Noriko Esumi; J Chang; M Kerrigan; M Campochiaro; Peter A Campochiaro; Krzysztof Palczewski; Donald J Zack
Cloning and characterization of a human beta,beta-carotene-15,15'-dioxygenase that is highly expressed in the retinal pigment epithelium.
Genomics 2001;72(2):193-202.
2001: Masahiko Shimura; Yukun Yuan; J T Chang; S Zhang; Peter A Campochiaro; Donald J Zack; Bret A Hughes
Expression and permeation properties of the K(+) channel Kir7.1 in the retinal pigment epithelium.
The Journal of physiology 2001;531(Pt 2):329-46.
2001: Sharon Fekrat; Sarah H Elsing; Sharath C Raja; Peter A Campochiaro; Eugene de JUAN; Julia A Haller
Eye pain after vitreoretinal surgery: a prospective study of 185 patients.
Retina (Philadelphia, Pa.) 2001;21(6):627-32.
2001: Eri Yamada; T Tobe; Haruhiko Yamada; Naoyuki Okamoto; Donald J Zack; Z Werb; P D Soloway; Peter A Campochiaro
TIMP-1 promotes VEGF-induced neovascularization in the retina.
Histology and histopathology 2001;16(1):87-97.
2000: Stanley A Vinores; Man-Seong Seo; Naoyuki Okamoto; J D Ash; E F Wawrousek; Wei-Hong Xiao; T Hudish; Nancy L Derevjanik; Peter A Campochiaro
Experimental models of growth factor-mediated angiogenesis and blood-retinal barrier breakdown.
General pharmacology 2000;35(5):233-9.
2000: Haruhiko Yamada; Eri Yamada; N Kwak; Akira Ando; A Suzuki; Noriko Esumi; Donald J Zack; Peter A Campochiaro
Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina.
Journal of cellular physiology 2000;185(1):135-42.
2000: Man-Seong Seo; Naoyuki Okamoto; MA Vinores; Stanley A Vinores; Sean F Hackett; Haruhiko Yamada; Eri Yamada; Nancy L Derevjanik; W LaRochelle; Donald J Zack; Peter A Campochiaro
Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment.
The American journal of pathology 2000;157(3):995-1005.
2000: N Kwak; Naoyuki Okamoto; JM Wood; Peter A Campochiaro
VEGF is major stimulator in model of choroidal neovascularization.
Investigative ophthalmology & visual science 2000;41(10):3158-64.
2000: Peter A Campochiaro
Retinal and choroidal neovascularization.
Journal of cellular physiology 2000;184(3):301-10.
2000: Sean F Hackett; H Ozaki; R W Strauss; Karl Wahlin; Chitra Suri; Peter C Maisonpierre; George D Yancopoulos; Peter A Campochiaro
Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization.
Journal of cellular physiology 2000;184(3):275-84.
2000: A Loewenstein; M S Humayun; E de Juan; Peter A Campochiaro; J A Haller
Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreoretinal surgery.
Ophthalmology 2000;107(6):1078-82.
2000: D Kent; Stanley A Vinores; Peter A Campochiaro
Macular oedema: the role of soluble mediators.
The British journal of ophthalmology 2000;84(5):542-5.
2000: Karl Wahlin; Peter A Campochiaro; Donald J Zack; Ruben Adler
Neurotrophic factors cause activation of intracellular signaling pathways in Müller cells and other cells of the inner retina, but not photoreceptors.
Investigative ophthalmology & visual science 2000;41(3):927-36.
2000: Doriano Fabbro; Stephan Ruetz; Stephan Bodis; Martin Pruschy; Katalin Csermak; Anthony Man; Peter A Campochiaro; J Wood; Terence O'Reilly; Thomas Meyer
PKC412--a protein kinase inhibitor with a broad therapeutic potential.
Anti-cancer drug design 2000;15(1):17-28.
2000: Jeevan Mathura; N Jafari; J T Chang; Sean F Hackett; Karl Wahlin; Neil G Della; Naoyuki Okamoto; Donald J Zack; Peter A Campochiaro
Bone morphogenetic proteins-2 and -4: negative growth regulators in adult retinal pigmented epithelium.
Investigative ophthalmology & visual science 2000;41(2):592-600.
2000: H Ozaki; Man-Seong Seo; K Ozaki; Haruhiko Yamada; Eri Yamada; Naoyuki Okamoto; F Hofmann; JM Wood; Peter A Campochiaro
Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.
The American journal of pathology 2000;156(2):697-707.
2000: Haruhiko Yamada; Eri Yamada; Akira Ando; Man-Seong Seo; Noriko Esumi; Naoyuki Okamoto; MA Vinores; W LaRochelle; Donald J Zack; Peter A Campochiaro
Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathy.
The American journal of pathology 2000;156(2):477-87.
2000: Stanley A Vinores; Nancy L Derevjanik; MA Vinores; Naoyuki Okamoto; Peter A Campochiaro
Sensitivity of different vascular beds in the eye to neovascularization and blood-retinal barrier breakdown in VEGF transgenic mice.
Advances in experimental medicine and biology 2000;476():129-38.
1999: Peter A Campochiaro; P Soloway; S J Ryan; J W Miller
The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration.
Molecular vision 1999;5():34.
1999: Shaker A Mousa; W Lorelli; Peter A Campochiaro
Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells.
Journal of cellular biochemistry 1999;74(1):135-43.
1999: Man-Seong Seo; N Kwak; H Ozaki; Haruhiko Yamada; Naoyuki Okamoto; Eri Yamada; D Fabbro; F Hofmann; JM Wood; Peter A Campochiaro
Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor.
The American journal of pathology 1999;154(6):1743-53.
1999: Haruhiko Yamada; Eri Yamada; Sean F Hackett; H Ozaki; Naoyuki Okamoto; Peter A Campochiaro
Hyperoxia causes decreased expression of vascular endothelial growth factor and endothelial cell apoptosis in adult retina.
Journal of cellular physiology 1999;179(2):149-56.
1999: Srinivas R Sadda; Peter A Campochiaro; Eugene de JUAN; Julia A Haller; W Richard Green
Histopathological features of vitreous removed at macular hole surgery.
Archives of ophthalmology 1999;117(4):478-84.
1999: J T Chang; Noriko Esumi; K Moore; Yingying Li; S Zhang; C Chew; B Goodman; Amir Rattner; S Moody; Gail Stetten; Peter A Campochiaro; Donald J Zack
Cloning and characterization of a secreted frizzled-related protein that is expressed by the retinal pigment epithelium.
Human molecular genetics 1999;8(4):575-83.
1999: Stanley A Vinores; Nancy L Derevjanik; H Ozaki; Naoyuki Okamoto; Peter A Campochiaro
Cellular mechanisms of blood-retinal barrier dysfunction in macular edema.
Documenta ophthalmologica. Advances in ophthalmology 1999;97(3-4):217-28.
1999: H Ozaki; AY Yu; Neil G Della; K Ozaki; JD Luna; Haruhiko Yamada; Sean F Hackett; Naoyuki Okamoto; Donald J Zack; Gregg L Semenza; Peter A Campochiaro
Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression.
Investigative ophthalmology & visual science 1999;40(1):182-9.
1998: T Tobe; Sagrario Ortega; JD Luna; H Ozaki; Naoyuki Okamoto; Nancy L Derevjanik; Stanley A Vinores; Claudio Basilico; Peter A Campochiaro
Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model.
The American journal of pathology 1998;153(5):1641-6.
1998: DA Swanson; J T Chang; Peter A Campochiaro; Donald J Zack; David Valle
Mammalian orthologs of C. elegans unc-119 highly expressed in photoreceptors.
Investigative ophthalmology & visual science 1998;39(11):2085-94.
1998: H Ozaki; Naoyuki Okamoto; Sagrario Ortega; M Chang; K Ozaki; Srinivas R Sadda; MA Vinores; Nancy L Derevjanik; Donald J Zack; Claudio Basilico; Peter A Campochiaro
Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization.
The American journal of pathology 1998;153(3):757-65.
1998: Stanley A Vinores; Chi-Chao Chan; MA Vinores; D M Matteson; YS Chen; DA Klein; A Shi; H Ozaki; Peter A Campochiaro
Increased vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGFbeta) in experimental autoimmune uveoretinitis: upregulation of VEGF without neovascularization.
Journal of neuroimmunology 1998;89(1-2):43-50.
1998: Alberto Perez-Mediavilla; C Chew; Peter A Campochiaro; R W Nickells; V Notario; Donald J Zack; S Patricia Becerra
Sequence and expression analysis of bovine pigment epithelium-derived factor.
Biochimica et biophysica acta 1998;1398(2):203-14.
1998: Sean F Hackett; Z Friedman; J Freund; CL Schoenfeld; Rory Curtis; P S DiStefano; Peter A Campochiaro
A splice variant of trkB and brain-derived neurotrophic factor are co-expressed in retinal pigmented epithelial cells and promote differentiated characteristics.
Brain research 1998;789(2):201-12.
1998: Breandán N Kennedy; S Goldflam; M A Chang; Peter A Campochiaro; A A Davis; Donald J Zack; John W Crabb
Transcriptional regulation of cellular retinaldehyde-binding protein in the retinal pigment epithelium. A role for the photoreceptor consensus element.
The Journal of biological chemistry 1998;273(10):5591-8.
1998: T Tobe; Naoyuki Okamoto; MA Vinores; Nancy L Derevjanik; Stanley A Vinores; Donald J Zack; Peter A Campochiaro
Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.
Investigative ophthalmology & visual science 1998;39(1):180-8.
1997: YS Chen; Sean F Hackett; CL Schoenfeld; MA Vinores; Stanley A Vinores; Peter A Campochiaro
Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes.
The British journal of ophthalmology 1997;81(10):919-26.
1997: JD Luna; Chi-Chao Chan; Nancy L Derevjanik; J Mahlow; C Chiu; B Peng; T Tobe; Peter A Campochiaro; Stanley A Vinores
Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown.
Journal of neuroscience research 1997;49(3):268-80.
1997: J T Chang; S Milligan; Yongbo Li; C E Chew; J Wiggs; Neal G Copeland; Nancy A Jenkins; Peter A Campochiaro; D R Hyde; Donald J Zack
Mammalian homolog of Drosophila retinal degeneration B rescues the mutant fly phenotype.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(15):5881-90.
1997: Susan Tonya Stefko; Peter A Campochiaro; P Wang; Y Li; D Zhu; Elias Traboulsi
Dominant inheritance of optic pits.
American journal of ophthalmology 1997;124(1):112-3.
1997: Naoyuki Okamoto; T Tobe; Sean F Hackett; H Ozaki; MA Vinores; W LaRochelle; Donald J Zack; Peter A Campochiaro
Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization.
The American journal of pathology 1997;151(1):281-91.
1997: Sean F Hackett; CL Schoenfeld; J Freund; John D Gottsch; S Bhargave; Peter A Campochiaro
Neurotrophic factors, cytokines and stress increase expression of basic fibroblast growth factor in retinal pigmented epithelial cells.
Experimental eye research 1997;64(6):865-73.
1997: Hiroaki Ozaki; Hideyuki Hayashi; Stanley A Vinores; Y Moromizato; Peter A Campochiaro; Kenji Oshima
Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates.
Experimental eye research 1997;64(4):505-17.
1997: Peter A Campochiaro
The Silicone Study. A small piece of the PVR puzzle is put into place.
Archives of ophthalmology 1997;115(3):407-8.
1997: Peter A Campochiaro
Pathogenic mechanisms in proliferative vitreoretinopathy.
Archives of ophthalmology 1997;115(2):237-41.
1997: Ingrid Zimmer-Galler; A Santos; Julia A Haller; Peter A Campochiaro
Management of endophthalmitis in a silicone oil-filled eye.
Retina (Philadelphia, Pa.) 1997;17(6):507-9.
1997: Stanley A Vinores; A I Youssri; JD Luna; YS Chen; S Bhargave; MA Vinores; CL Schoenfeld; B Peng; Chi-Chao Chan; W LaRochelle; W Richard Green; Peter A Campochiaro
Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
Histology and histopathology 1997;12(1):99-109.
1996: JD Luna; T Tobe; S A Mousa; T M Reilly; Peter A Campochiaro
Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model.
Laboratory investigation; a journal of technical methods and pathology 1996;75(4):563-73.
1996: N G Della; Peter A Campochiaro; Donald J Zack
Localization of TIMP-3 mRNA expression to the retinal pigment epithelium.
Investigative ophthalmology & visual science 1996;37(9):1921-4.
1996: H S Lazarus; CL Schoenfeld; Sharon Fekrat; S Cohen; A Carol; Gregory S Hageman; Sean F Hackett; Y S Chen; Stanley A Vinores; Peter A Campochiaro
Hyalocytes synthesize and secrete inhibitors of retinal pigment epithelial cell proliferation in vitro.
Archives of ophthalmology 1996;114(6):731-6.
1996: Peter A Campochiaro; M Chang; M Ohsato; Stanley A Vinores; Z Nie; Leonard M Hjelmeland; Alka Mansukhani; Claudio Basilico; Donald J Zack
Retinal degeneration in transgenic mice with photoreceptor-specific expression of a dominant-negative fibroblast growth factor receptor.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1996;16(5):1679-88.
1995: Stanley A Vinores; M Küchle; J Mahlow; C Chiu; W Richard Green; Peter A Campochiaro
Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor.
The American journal of pathology 1995;147(5):1289-97.
1995: Stanley A Vinores; M Küchle; Nancy L Derevjanik; Jeffrey D Henderer; J Mahlow; W Richard Green; Peter A Campochiaro
Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization.
Histology and histopathology 1995;10(4):913-23.
1995: Stanley A Vinores; Jeffrey D Henderer; J Mahlow; C Chiu; Nancy L Derevjanik; W LaRochelle; C Csaky; Peter A Campochiaro
Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells.
Experimental eye research 1995;60(6):607-19.
1995: Stanley A Vinores; Nancy L Derevjanik; J Mahlow; Sean F Hackett; J A Haller; E deJuan; Anthony Frankfurter; Peter A Campochiaro
Class III beta-tubulin in human retinal pigment epithelial cells in culture and in epiretinal membranes.
Experimental eye research 1995;60(4):385-400.
1995: Sharon Fekrat; Eugene de JUAN; Peter A Campochiaro
The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy.
Ophthalmology 1995;102(3):412-8.
1994: Peter A Campochiaro; Sean F Hackett; Stanley A Vinores; J Freund; C Csaky; W LaRochelle; Jeffrey D Henderer; Mary A Johnson; I R Rodriguez; Z Friedman
Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells.
Journal of cell science 1994;107 ( Pt 9)():2459-69.
1994: Stanley A Vinores; A Amin; Nancy L Derevjanik; W Richard Green; Peter A Campochiaro
Immunohistochemical localization of blood-retinal barrier breakdown sites associated with post-surgical macular oedema.
The Histochemical journal 1994;26(8):655-65.
1994: Jennifer I Lim; Cheryl Enger; Julia A Haller; Peter A Campochiaro; Travis Meredith; S de Bustros; James P Dunn; Douglas A Jabs
Improved visual results after surgical repair of cytomegalovirus-related retinal detachments.
Ophthalmology 1994;101(2):264-9.
1994: Peter A Campochiaro; Jennifer I Lim
Aminoglycoside toxicity in the treatment of endophthalmitis. The Aminoglycoside Toxicity Study Group.
Archives of ophthalmology 1994;112(1):48-53.
1993: Stanley A Vinores; E Van Niel; J L Swerdloff; Peter A Campochiaro
Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
Experimental eye research 1993;57(6):723-35.
1993: Peter A Campochiaro; Sean F Hackett
Corneal endothelial cell matrix promotes expression of differentiated features of retinal pigmented epithelial cells: implication of laminin and basic fibroblast growth factor as active components.
Experimental eye research 1993;57(5):539-47.
1993: Stanley A Vinores; E Van Niel; J L Swerdloff; Peter A Campochiaro
Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium.
The Histochemical journal 1993;25(9):648-63.
1993: Stanley A Vinores; W Orman; J J Hooks; Barbara Detrick; Peter A Campochiaro
Ultrastructural localization of RPE-associated epitopes recognized by monoclonal antibodies in human RPE and their induction in human fibroblasts by vitreous.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 1993;231(7):395-401.
1993: J Hines; Stanley A Vinores; Peter A Campochiaro
Evolution of morphologic changes after intravitreous injection of gentamicin.
Current eye research 1993;12(6):521-9.
1993: Sean F Hackett; Peter A Campochiaro
Modulation of plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells.
Investigative ophthalmology & visual science 1993;34(6):2055-61.
1993: Stanley A Vinores; M M Herman; Sean F Hackett; Peter A Campochiaro
A morphological and immunohistochemical study of human retinal pigment epithelial cells, retinal glia, and fibroblasts grown on Gelfoam matrix in an organ culture system. A comparison of structural and nonstructural proteins and their application to cell type identification.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 1993;231(5):279-88.
1993: B M Glaser; J Vidaurri-Leal; R G Michels; Peter A Campochiaro
Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells.
Ophthalmology 1993;100(4):466-70.
1993: Peter A Campochiaro
Cytokine production by retinal pigmented epithelial cells.
International review of cytology 1993;146():75-82.
1992: Jennifer I Lim; Peter A Campochiaro
Successful treatment of gram-negative endophthalmitis with intravitreous ceftazidime.
Archives of ophthalmology 1992;110(12):1686.
1992: Peter A Campochiaro; W Richard Green
Toxicity of intravitreous ceftazidime in primate retina.
Archives of ophthalmology 1992;110(11):1625-9.
1992: Stanley A Vinores; E Van Niel; H J Kim; Peter A Campochiaro
Simultaneous expression of keratin and glial fibrillary acidic protein by the same cells in epiretinal membranes.
Investigative ophthalmology & visual science 1992;33(12):3361-6.
1992: B D Greenwald; A R Tunkel; K M Morgan; Peter A Campochiaro; G R Donowitz
Candidal endophthalmitis after lithotripsy of renal calculi.
Southern medical journal 1992;85(7):773-4.
1992: J A Haller; Peter A Campochiaro
Oil and gas on troubled waters. The proliferative vitreoretinopathy studies.
Archives of ophthalmology 1992;110(6):768-9.
1992: Stanley A Vinores; H Sen; Peter A Campochiaro
An adenosine agonist and prostaglandin E1 cause breakdown of the blood-retinal barrier by opening tight junctions between vascular endothelial cells.
Investigative ophthalmology & visual science 1992;33(6):1870-8.
1992: Peter A Campochiaro; Federico Gonzalez-Fernandez; Steven A Newman; Brian P Conway; P S Feldman
Ciliary body adenoma in a 10-year-old girl who had a rhabdomyosarcoma.
Archives of ophthalmology 1992;110(5):681-3.
1992: Peter A Campochiaro; E Van Niel; Stanley A Vinores
Immunocytochemical labeling of cells in cortical vitreous from patients with premacular hole lesions.
Archives of ophthalmology 1992;110(3):371-7.
1991: Z Friedman; T M Delahunty; Joel Linden; Peter A Campochiaro
Human retinal pigment epithelial cells possess V1 vasopressin receptors.
Current eye research 1991;10(9):811-6.
1991: Peter A Campochiaro; Brian P Conway
Aminoglycoside toxicity--a survey of retinal specialists. Implications for ocular use.
Archives of ophthalmology 1991;109(7):946-50.
1991: Sean F Hackett; J H Singer; K H Leschey; Peter A Campochiaro
Thrombin is a stimulator of retinal pigment epithelial cell proliferation.
Experimental eye research 1991;53(1):95-100.
1991: H A Sen; Peter A Campochiaro
Stimulation of cyclic adenosine monophosphate accumulation causes breakdown of the blood-retinal barrier.
Investigative ophthalmology & visual science 1991;32(7):2006-10.
1991: K H Leschey; J Hines; J H Singer; Sean F Hackett; Peter A Campochiaro
Inhibition of growth factor effects in retinal pigment epithelial cells.
Investigative ophthalmology & visual science 1991;32(6):1770-8.
1991: Peter A Campochiaro; Sean F Hackett; Brian P Conway
Retinoic acid promotes density-dependent growth arrest in human retinal pigment epithelial cells.
Investigative ophthalmology & visual science 1991;32(1):65-72.
1990: Stanley A Vinores; Peter A Campochiaro; R McGehee; W Orman; Sean F Hackett; Leonard M Hjelmeland
Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia, and fibroblasts in vitreous culture.
Investigative ophthalmology & visual science 1990;31(12):2529-45.
1990: Stanley A Vinores; R McGehee; A Lee; Crystal A Gadegbeku; Peter A Campochiaro
Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1990;38(9):1341-52.
1990: Peter A Campochiaro; K M Morgan; Brian P Conway; J Stathos
Spontaneous involution of subfoveal neovascularization.
American journal of ophthalmology 1990;109(6):668-75.
1990: Stanley A Vinores; Peter A Campochiaro; A Lee; R McGehee; Crystal A Gadegbeku; W Richard Green
Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albumin.
Laboratory investigation; a journal of technical methods and pathology 1990;62(6):742-50.
1990: K H Leschey; Sean F Hackett; J H Singer; Peter A Campochiaro
Growth factor responsiveness of human retinal pigment epithelial cells.
Investigative ophthalmology & visual science 1990;31(5):839-46.
1990: Stanley A Vinores; Peter A Campochiaro; Brian P Conway
Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes.
Investigative ophthalmology & visual science 1990;31(1):14-28.
1989: H A Sen; Peter A Campochiaro
Intravitreous injection of adenosine or its agonists causes breakdown of the blood-retinal barrier.
Archives of ophthalmology 1989;107(9):1364-7.
1989: Stanley A Vinores; Peter A Campochiaro
Prevention or moderation of some ultrastructural changes in the RPE and retina of galactosemic rats by aldose reductase inhibition.
Experimental eye research 1989;49(3):495-510.
1989: Peter A Campochiaro; R Sugg; Gary Grotendorst; Leonard M Hjelmeland
Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media.
Experimental eye research 1989;49(2):217-27.
1989: M Cowley; Brian P Conway; Peter A Campochiaro; D Kaiser; H Gaskin
Clinical risk factors for proliferative vitreoretinopathy.
Archives of ophthalmology 1989;107(8):1147-51.
1989: Peter A Campochiaro; J Mimuro; R Sugg; D J Loskutoff
Retinal pigment epithelial cells produce a latent fibrinolytic inhibitor that is antigenically and biochemically related to type 1 plasminogen activator inhibitor produced by vascular endothelial cells.
Experimental eye research 1989;49(2):195-203.
1989: Z Friedman; Sean F Hackett; Joel Linden; Peter A Campochiaro
Human retinal pigment epithelial cells in culture possess A2-adenosine receptors.
Brain research 1989;492(1-2):29-35.
1989: Sean F Hackett; Brian P Conway; Peter A Campochiaro
Subretinal fluid stimulation of retinal pigment epithelial cell migration and proliferation is dependent on certain features of the detachment or its treatment.
Archives of ophthalmology 1989;107(3):391-4.
1989: Peter A Campochiaro; H A Sen
Adenosine and its agonists cause retinal vasodilation and hemorrhages. Implications for ischemic retinopathies.
Archives of ophthalmology 1989;107(3):412-6.
1989: Stanley A Vinores; Crystal A Gadegbeku; Peter A Campochiaro; W Richard Green
Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics.
The American journal of pathology 1989;134(2):231-5.
1989: Brian P Conway; C A Tabatabay; Peter A Campochiaro; D J D'Amico; L A Hanninen; K R Kenyon
Gentamicin toxicity in the primate retina.
Archives of ophthalmology 1989;107(1):107-12.
1988: M Cowley; Peter A Campochiaro; S A Newman; J A Fogle
Retinal vascular occlusion without retrobulbar or optic nerve sheath hemorrhage after retrobulbar injection of lidocaine.
Ophthalmic surgery 1988;19(12):859-61.
1988: Stanley A Vinores; Peter A Campochiaro; E H Williams; E E May; W Richard Green; R L Sorenson
Aldose reductase expression in human diabetic retina and retinal pigment epithelium.
Diabetes 1988;37(12):1658-64.
1988: Peter A Campochiaro
Retinal thinning and regression of neovascularization.
Archives of ophthalmology 1988;106(12):1646-7.
1988: Peter A Campochiaro; Brian P Conway
Hemangiomalike masses of the retina.
Archives of ophthalmology 1988;106(10):1409-13.
1988: H A Sen; T J Robertson; Brian P Conway; Peter A Campochiaro
The role of breakdown of the blood-retinal barrier in cell-injection models of proliferative vitreoretinopathy.
Archives of ophthalmology 1988;106(9):1291-4.
1988: Peter A Campochiaro; S H Blaydes
Photocoagulation does not ablate angiogenic markers in rabbit retina.
Archives of ophthalmology 1988;106(5):676-9.
1988: Z Friedman; Sean F Hackett; Peter A Campochiaro
Human retinal pigment epithelial cells possess muscarinic receptors coupled to calcium mobilization.
Brain research 1988;446(1):11-6.
1988: Stanley A Vinores; Peter A Campochiaro; E E May; S H Blaydes
Progressive ultrastructural damage and thickening of the basement membrane of the retinal pigment epithelium in spontaneously diabetic BB rats.
Experimental eye research 1988;46(4):545-58.
1988: Sean F Hackett; Peter A Campochiaro
Implication of protein carboxymethylation in retinal pigment epithelial cell chemotaxis.
Ophthalmic research 1988;20(1):54-9.
1988: B M Glaser; Peter A Campochiaro; J L Davis; M Sato
Retinal pigment epithelial cells release an inhibitor of neovascularization.
Birth defects original article series 1988;24(1):121-7.
1987: W G Wilson; Peter A Campochiaro; Brian P Conway; B T Carter; K W Sudduth; B A Watson; R S Sparkes
Deletion (13)(q14.1q14.3) in two generations: variability of ocular manifestations and definition of the phenotype.
American journal of medical genetics 1987;28(3):675-83.
1987: Peter A Campochiaro; H C Gaskin; Stanley A Vinores
Retinal cryopexy stimulates traction retinal detachment formation in the presence of an ocular wound.
Archives of ophthalmology 1987;105(11):1567-70.
1987: B M Glaser; Peter A Campochiaro; J L Davis; J A Jerdan
Retinal pigment epithelial cells release inhibitors of neovascularization.
Ophthalmology 1987;94(7):780-4.
1987: C Dircks; E H Williams; Peter A Campochiaro
High glucose concentrations inhibit protein synthesis in retinal pigment epithelium in vitro.
Experimental eye research 1987;44(6):951-8.
1987: Sean F Hackett; Z Friedman; Peter A Campochiaro
Cyclic 3',5'-adenosine monophosphate modulates vascular endothelial cell migration in vitro.
Cell biology international reports 1987;11(4):279-87.
1987: Z Friedman; Sean F Hackett; Peter A Campochiaro
Characterization of adenylate cyclase in human retinal pigment epithelial cells in vitro.
Experimental eye research 1987;44(4):471-9.
1987: J H Stahl; D B Miller; Brian P Conway; Peter A Campochiaro
Dexamethasone and indomethacin attenuate cryopexy. Induced breakdown of the blood-retinal barrier.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 1987;225(6):418-20.
1986: Peter A Campochiaro; J A Bryan; B P Conway; E H Jaccoma
Intravitreal chemotactic and mitogenic activity. Implication of blood-retinal barrier breakdown.
Archives of ophthalmology 1986;104(11):1685-7.
1986: Peter A Campochiaro; J A Jerdon; B M Glaser
The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro.
Investigative ophthalmology & visual science 1986;27(11):1615-21.
1986: Sean F Hackett; Z Friedman; Peter A Campochiaro
Cyclic 3',5'-adenosine monophosphate modulates retinal pigment epithelial cell migration in vitro.
Archives of ophthalmology 1986;104(11):1688-92.
1986: Peter A Campochiaro; B M Glaser
A retina-derived stimulator(s) of retinal pigment epithelial cell and astrocyte proliferation.
Experimental eye research 1986;43(3):449-57.
1986: J A Bryan; Peter A Campochiaro
A retinal pigment epithelial cell-derived growth factor(s).
Archives of ophthalmology 1986;104(3):422-5.
1986: J H Yeo; J Sadeghi; Peter A Campochiaro; W Richard Green; B M Glaser
Intravitreous fibronectin and platelet-derived growth factor. New model for traction retinal detachment.
Archives of ophthalmology 1986;104(3):417-21.
1986: B P Conway; Peter A Campochiaro
Macular infarction after endophthalmitis treated with vitrectomy and intravitreal gentamicin.
Archives of ophthalmology 1986;104(3):367-71.
1986: Peter A Campochiaro; B M Glaser
Mechanisms involved in retinal pigment epithelial cell chemotaxis.
Archives of ophthalmology 1986;104(2):277-80.
1985: Peter A Campochiaro; B M Glaser
Endothelial cells release a chemoattractant for retinal pigment epithelial cells in vitro.
Archives of ophthalmology 1985;103(12):1876-80.
1985: B M Glaser; Peter A Campochiaro; J L Davis; M Sato
Retinal pigment epithelial cells release an inhibitor of neovascularization.
Archives of ophthalmology 1985;103(12):1870-5.
1985: E H Jaccoma; B P Conway; Peter A Campochiaro
Cryotherapy causes extensive breakdown of the blood-retinal barrier. A comparison with argon laser photocoagulation.
Archives of ophthalmology 1985;103(11):1728-30.
1985: Peter A Campochiaro; J A Jerdan; B M Glaser; A Cardin; R G Michels
Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration.
Archives of ophthalmology 1985;103(9):1403-5.
1985: Peter A Campochiaro; B M Glaser
Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells.
Archives of ophthalmology 1985;103(4):576-9.
1985: Peter A Campochiaro; I H Kaden; J Vidaurri-Leal; B M Glaser
Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells.
Archives of ophthalmology 1985;103(3):434-6.
1985: Peter A Campochiaro; J W Ferkany; J T Coyle
Excitatory amino acid analogs evoke release of endogenous amino acids and acetyl choline from chick retina in vitro.
Vision research 1985;25(10):1375-86.
1984: Peter A Campochiaro; J A Jerdan; B M Glaser
Serum contains chemoattractants for human retinal pigment epithelial cells.
Archives of ophthalmology 1984;102(12):1830-3.
1984: Peter A Campochiaro; J W Ferkany; J T Coyle
The dissociation of evoked release of [3H]-GABA and of endogenous GABA from chick retina in vitro.
Experimental eye research 1984;39(3):299-305.
1978: Peter A Campochiaro; J T Coyle
Ontogenetic development of kainate neurotoxicity: correlates with glutamatergic innervation.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(4):2025-9.
1977: Peter A Campochiaro; Robert Schwarcz; J T Coyle
GABA receptor binding in rat striatum: localization and effects of denervation.
Brain research 1977;136(3):501-11.
1977: J T Coyle; Robert Schwarcz; J P Bennett; Peter A Campochiaro
Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: correlates with a new animal model.
Progress in neuro-psychopharmacology 1977;1(1-2):13-30.
1976: J T Coyle; Peter A Campochiaro
Ontogenesis of dopaminergic-cholinergic interactions in the rat striatum: a neurochemical study.
Journal of neurochemistry 1976;27(3):673-8.